glp-1 malnutrition and Sarcopenia as Reasons for Caution with Receptor Agonist Use in HFpEF GLP-1 Side Effect Management: Nutrition
Description
The association remains largely observational and patient-reported rather than formally quantified in controlled studies
Neurochemical characterization of body weight-regulating leptin receptor neurons in the nucleus of the solitary tract
The best letters connect your obesity to specific health outcomes, reference clinical guidelines supporting GLP-1 use, and explain why alternative treatments have been insufficient
Although numerous studies have compared the available GLP-1 receptor agonists, few have directly explored the effects of switching between these agents, highlighting a need for further research
Microbial Ecology, 75 (1), 228-238
